AltaThera Pharmaceuticals的封面图片
AltaThera Pharmaceuticals

AltaThera Pharmaceuticals

制药业

Chicago,Illinois 7,641 位关注者

AltaThera is a precision medicine company using innovative science to improve patient care.

关于我们

AltaThera is a precision medicine company using innovative science to improve patient care. We aim to narrow the gap between scientific innovation and clinical decision-making by individualizing drug treatment so that the right patient can receive the right dose at the right time.

网站
https://altathera.com/
所属行业
制药业
规模
11-50 人
总部
Chicago,Illinois
类型
私人持股
领域
Specialty Pharmaceuticals、Critical Care Products、Rare Disease Products、Partnering with Patient Advocacy Groups和Pharmaceutics

地点

  • 主要

    311 S Wacker Dr

    Suite 6030

    US,Illinois,Chicago,60606

    获取路线

AltaThera Pharmaceuticals员工

动态

  • We're excited to be attending Heart Rhythm Society's #HRS2024 in Boston! If you're attending, stop by booth 763 and learn how a 1-hour loading dose of Sotalol IV may potentially shorten patient length of stay and increase bed availability at hospitals.* (We'll also have coffee?) Interested in learning more about Sotalol IV while at the conference? Attend the May 17 poster presentation, “Correlation of Mobile ECG with 12-Lead ECG Findings During Intravenous Sotalol Loading for Atrial Fibrillation”, authored by Benjamin A. Steinberg, MD, MHS et al. at the Abstract Pavilion. For more information about this poster and the conference program, please visit the Heart Rhythm 2024 website at https://heartrhythm.com. See you in Boston! *Sotalol IV [package insert]. Chicago, IL: AltaThera Pharmaceuticals; 09/2023. WARNING: Life Threatening Proarrhythmia. Please see Sotalol IV Highlights of Prescribing Information and full Prescribing Information at https://lnkd.in/dT-ayk23, including boxed warning, contraindications, and dosing.?

  • 查看AltaThera Pharmaceuticals的组织主页

    7,641 位关注者

    Are you attending American College of Cardiology's ACC.24 in Atlanta? Be sure to stop by booth 1809 and learn how a 1-hour loading dose of Sotalol IV may potentially shorten patient length of stay and increase bed availability at hospitals.* ACC.24 attendees will be able gain insight into one health system’s experience with Sotalol IV by attending the April 6 poster presentation, “Real-World Comparative Effectiveness and Safety of Intravenous to Oral Sotalol Loading Among Patients with Atrial Arrhythmias”, authored by Keturah Weaver, PharmD, BCPS, Benjamin Heikkinen, PharmD, BCIDP, and Melinda Novak, PharmD. For more information about this poster and the conference program, please visit the ACC.24 website at https://lnkd.in/gkrcJVn. See you in Atlanta! #acc2024 #acc24 *Sotalol IV [package insert]. Chicago, IL: AltaThera Pharmaceuticals; 09/2023.? WARNING: Life Threatening Proarrhythmia. Please see Sotalol IV Highlights of Prescribing Information and full Prescribing Information at?sotaloliv.com/pi, including boxed warning, contraindications, and dosing.?

相似主页

查看职位